Kolexia
Nifle Chantal Neurologie
Nifle Chantal
Neurologie
Centre hospitalier de Versailles
Le Chesnay, France
42 Activités
11 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose Sclérose en plaques Sclérose en plaques récurrente-rémittente Artériopathies oblitérantes Maladies démyélinisantes Sclérose en plaques chronique progressive Infarctus cérébral Spondylarthrite Coma

Collaborateurs

Voir plus
Heinzlef Olivier
Heinzlef Olivier
Chi Poissy St Germain Site De Poissy, Poissy, France
Pico Fernando
Pico Fernando
Centre hospitalier de Versailles, Le Chesnay, France
Stankoff Bruno
Stankoff Bruno
Hôpital Tenon, Paris, France
Frenay Christine
Frenay Christine
Hôpital Pasteur, Nice, France

Industries

Voir plus
Sanofi
7 collaboration(s)
Dernière en 2023
Merck-Serono
5 collaboration(s)
Dernière en 2023
Novartis
3 collaboration(s)
Dernière en 2023
Roche
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
Neurology   23 décembre 2022
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Multiple sclerosis (Houndmills, Basingstoke, England)   14 décembre 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
BMC medical research methodology   30 mai 2022
Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system
Multiple sclerosis (Houndmills, Basingstoke, England) Congress 2021   12 octobre 2021
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
CNS drugs   18 septembre 2021
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.
Multiple sclerosis and related disorders   08 mai 2021
Untreated patients with multiple sclerosis: A study of French expert centers.
European journal of neurology   19 mars 2021
Determinants of therapeutic lag in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)   11 janvier 2021
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
JAMA neurology   13 novembre 2020
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
Neurology   12 juillet 2019